The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Divoc are not using our tests yet!.....we need the FDA EUA to be able to sell there (I’ve given up on the icmr).
As for the placing nonsense....We have started selling through BC as per the 17th of Feb RNS. Also the kits are on sale in the EU and U.K. They are selling which is great, given the profit margins on them why would we need to place? Also still had £5.1m in the bank as for 31st October with no debt.
Lol it is indeed a good word!
The potential for Genedrive is staring me in the face. They are now finally selling the test in the U.K./EU and the US. We also have several other assays either at market or about to be launched. The MT-RNR1 ID kit will cover our mcap alone when launched!
BC are currently selling our tests, phone them and ask! They will confirm that Genedrive tests are being sold, they obviously will not confirm price sensitive info. Next week we will get an update on how BC are getting on with our kits.
https://twitter.com/sharemuncher/status/1372914860099534857?s=21
I have covid lab experience and if the lab I work in had our test with the Biomek I7 it would cut out so much wasted time and extra staff that have to prep the current tests before going into the pcr machines. Our test really is 100% and as per a Beckman salesman environmentally friendly!
The Market wants to know how much Genedrive are selling which is fair enough. Hopefully we get an idea of the initial numbers from Beckman Coulter. Shares go up and they go down in the short term but as Genedrive tweeted this is kick off time.